Individuals with allergic diseases, particularly allergic rhinitis, have a higher risk of developing optic neuritis than those without such conditions, a recent study shows.
A new large-scale population-based study published in Scientific Reports has identified a noteworthy link between allergic ...
Successful meeting with FDA enables advancement into pivotal development with Privosegtor in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Oculis will launch ...
—A large data analysis found a significantly heightened relative risk of optic neuritis in NMOSD, MOGAD, and other inflammatory diseases, supporting prompt evaluation of visual complaints in these ...
Privosegtor is Oculis ' second ophthalmic drug to start a pivotal trials programme after OCS-01, a topical anti-TNF drug in ...
Privosegtor (also known as OCS-05) is a “first-in-class peptoid small molecule” for neuroprotective therapy for acute optic ...
My daughter, my oldest baby, just turned 21. Six weeks after the joy of her birth came a not so pleasant gift: my diagnosis of multiple sclerosis. Eighteen months later she was an active toddler, ...
ZUG, Switzerland, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and ...
A 71-year-old man was referred by his usual ophthalmologist to the neuro-ophthalmology clinic at Tufts Medical Center for bilateral decreased vision associated with bilateral optic disc edema. His ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback